Contrast-enhanced cardiovascular magnetic resonance in the hyperacute phase of ST-elevation myocardial infarction

被引：0
作者：
Eric Larose
Julie Côté
Josep Rodés-Cabau
Bernard Noël
Gerald Barbeau
Edith Bordeleau
Santiago Miró
Bernard Brochu
Robert Delarochellière
Olivier F. Bertrand
机构：
[1] Institut universitaire de cardiologie et de pneumologie de Québec and Faculté de médecine de l’Université Laval,Département multidisciplinaire de cardiologie
[2] Institut universitaire de cardiologie et de pneumologie de Québec and Faculté de médecine de l’Université Laval,Département d’imagerie médicale
来源：
The International Journal of Cardiovascular Imaging | 2009年 / 25卷
关键词：
Acute myocardial infarction; Magnetic resonance imaging; Primary coronary angioplasty; Contrast nephropathy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cardiovascular magnetic resonance (CMR) very early after primary percutaneous coronary intervention (PPCI) may lead to instability or early stent complications. However, CMR in the hyperacute phase of STEMI may improve risk stratification. We investigated feasibility and safety of CMR in the hyperacute phase of STEMI immediately after PPCI. One hundred and twenty eight consecutive patients immediately after PPCI for STEMI. Sixty four underwent CMR <12 h after PPCI versus 64 matched controls. Outcomes were followed over 6 months. CMR in hyperacute STEMI was not associated with in-hospital death, infarct expansion, or urgent revascularization (P = NS). CMR (32 ml gadolinium contrast) immediately after PPCI (180 ml iodine contrast) did not increase nephropathy. CMR did not increase major adverse cardiac events (5 vs. 8%, P = 0.16) or recurrence of angina (6 vs. 8%, P = 0.73) at 6 months. CMR immediately after PPCI is feasible and safe, allowing very early risk stratification in STEMI.
引用
收藏
页码：519 / 527
页数：8
相关论文
共 117 条
[1]  
Yan AT(2006)Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality Circulation 114 32-39
[2]  
Shayne AJ(2003)Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction Circulation 108 III28-III37
[3]  
Brown KA(2007)Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging Eur Heart J 28 1433-1439
[4]  
Braunwald E(2004)ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) Circulation 110 e82-e292
[5]  
Thiele H(2006)Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures Catheter Cardiovasc Interv 67 175-180
[6]  
Kappl MJ(2002)Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 2259-2264
[7]  
Linke A(2002)Magnetic resonance safety update 2002: implants and devices J Magn Reson Imaging 16 485-496
[8]  
Antman EM(1999)Behaviour of implantable coronary stents during magnetic resonance imaging Int J Cardiovasc Intervent 2 217-222
[9]  
Anbe DT(2003)Clinical safety of magnetic resonance imaging early after coronary artery stent placement J Am Coll Cardiol 42 1295-1298
[10]  
Armstrong PW(2005)Safety of magnetic resonance imaging one to three days after bare metal and drug-eluting stent implantation Am J Cardiol 96 366-368
12345678910